CIK 0001835579 · <br>Emerging growth company
ImageneBio, Inc.
Sign in to watch- Ticker
- IMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811697316
- Phone
- 857-343-8292
- Business address
- 12526 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Former names
- Ikena Oncology, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-30 | Atlas Venture Fund X, L.P. 10% owner | Conversion · Series A Preferred Stock | −9,499,999 | 0 | ||
| 2021-03-30 | Atlas Venture Fund X, L.P. 10% owner | Conversion · Series A-1 Preferred Stock | −11,258,117 | 0 | ||
| 2021-03-30 | Atlas Venture Fund X, L.P. 10% owner | Conversion · Series A-2 Preferred Stock | −7,863,094 | 0 | ||
| 2021-03-30 | Atlas Venture Fund X, L.P. 10% owner | Conversion · Series B Preferred Stock | −5,362,888 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion | +1,816,425 | 1,816,425 | ||
| 2021-03-30 | Bonita David P Director | Conversion | +68,978 | 68,978 | ||
| 2021-03-30 | Bonita David P Director | Purchase | +375,000 | $16.00 | $6.0M | 2,191,425 |
| 2021-03-30 | Bonita David P Director | Purchase | +48,400 | $16.00 | $774K | 117,378 |
| 2021-03-30 | Bonita David P Director | Conversion | +5,083,470 | 5,083,470 | ||
| 2021-03-30 | Bonita David P Director | Conversion | +130,924 | 130,924 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series A Preferred Stock | −1,905,201 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series A Preferred Stock | −680,766 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series A-1 Preferred Stock | −2,257,785 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series A-1 Preferred Stock | −806,752 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series B Preferred Stock | −920,484 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series B Preferred Stock | −328,907 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series B Preferred Stock | −130,924 | 0 | ||
| 2021-03-30 | Bonita David P Director | Conversion · Series B Preferred Stock | −68,978 | 0 | ||
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Conversion | +1,816,425 | 1,816,425 | ||
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Conversion | +68,978 | 68,978 |
Page 10 of 12 · 222 trades